Search Results - "Verhorst, Patrick M."

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe by Sokolski, Mateusz, Gajewski, Piotr, Zymliński, Robert, Biegus, Jan, Berg, Jurrien M. Ten, Bor, Wilbert, Braunschweig, Frieder, Caldeira, Daniel, Cuculi, Florim, D'Elia, Emilia, Edes, Istvan Ferenc, Garus, Mateusz, Greenwood, John P., Halfwerk, Frank R., Hindricks, Gerhard, Knuuti, Juhani, Kristensen, Steen Dalby, Landmesser, Ulf, Lund, Lars H., Lyon, Alexander, Mebazaa, Alexandre, Merkely, Béla, Nawrocka-Millward, Sylwia, Pinto, Fausto J., Ruschitzka, Frank, Semedo, Edimir, Senni, Michele, Sepehri Shamloo, Alireza, Sorensen, Jacob, Stengaard, Carsten, Thiele, Holger, Toggweiler, Stefan, Tukiendorf, Andrzej, Verhorst, Patrick M., Wright, David Jay, Zamorano, Pepe, Zuber, Michel, Narula, Jagat, Bax, Jeroen J., Ponikowski, Piotr

“…We evaluated whether the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) pandemic was associated with changes in the pattern of acute…”
Get full text

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial by von Birgelen, Clemens, PhD, Sen, Hanim, MD, Lam, Ming Kai, MD, Danse, Peter W, PhD, Jessurun, Gillian A J, PhD, Hautvast, Raymond W M, PhD, van Houwelingen, Gert K, MD, Schramm, Alexander R, MD, Gin, R Melvyn Tjon Joe, MD, Louwerenburg, Johannes W, MD, de Man, Frits H A F, PhD, Stoel, Martin G, PhD, Löwik, Marije M, PhD, Linssen, Gerard C M, PhD, Saïd, Salah A M, PhD, Nienhuis, Mark B, PhD, Verhorst, Patrick M J, PhD, Basalus, Mounir W Z, PhD, Doggen, Carine J M, PhD, Tandjung, Kenneth, MD

“…Summary Background Third-generation, permanent-polymer-based drug-eluting stents with novel, flexible designs might be more easily delivered than previous…”
Get full text

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial by TANDJUNG, Kenneth, SEN, Hanim, NIENHUIS, Mark B, LÖWIK, Marije M, VERHORST, Patrick M. J, DER PALEN, Job Van, VON BIRGELEN, Clemens, KAI LAM, Ming, BASALUS, Mounir W. Z, LOUWERENBURG, J. (hans) W, STOEL, Martin G, HOUWELINGEN, K. Gert Van, DE MAN, Frits H. A. F, LINSSEN, Gerard C. M, SAID, Salah A. M

“…The aim of this study was to assess the safety and efficacy of the implantation of Resolute zotarolimus-eluting stents (ZES) (Medtronic Inc., Santa Rosa,…”
Get full text

Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries by Hartmann, Marc, von Birgelen, Clemens, Mintz, Gary S., Stoel, Martin G., Eggebrecht, Holger, Wieneke, Heinrich, Fahy, Martin, Neumann, Till, van der Palen, Job, Louwerenburg, Hans W., Verhorst, Patrick M.J., Erbel, Raimund

“…Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries Marc Hartmann, Clemens von…”
Get full text

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents by SEN, Hanim, TANDJUNG, Kenneth, NIENHUIS, Mark B, VERHORST, Patrick M. J, VAN DER PALEN, Job, VON BIRGELEN, Clemens, BASALUS, Mounir W. Z, LÖWIK, Marije M, VAN HOUWELINGEN, Gert K, STOEL, Martin G, LOUWERENBURG, Hans W, DE MAN, Frits H. A. F, LINSSEN, Gerard C. M, NIJHUIS, Rogier

“…The TWENTE trial recently enrolled more than 80% of all eligible patients, who were randomised to zotarolimus-eluting Resolute or everolimus-eluting XIENCE V…”
Get full text

Staged Therapeutic Approach in Spontaneous Coronary Dissection by Aliyary, Siamak, MD, Mariani, Massimo A., MD, PhD, Verhorst, Patrick M.J., MD, PhD, Hartmann, Marc, MD, Stoel, Martin G., MD, von Birgelen, Clemens, MD, PhD

“…Spontaneous coronary artery dissection is an extremely rare event occurring especially in pregnant women, either peripartum or postpartum. Urgent coronary…”
Get full text

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial by von Birgelen, Clemens, Basalus, Mounir W Z, Tandjung, Kenneth, van Houwelingen, K Gert, Stoel, Martin G, Louwerenburg, J Hans W, Linssen, Gerard C M, Saïd, Salah A M, Kleijne, Miep A W J, Sen, Hanim, Löwik, Marije M, van der Palen, Job, Verhorst, Patrick M J, de Man, Frits H A F

“…The aim of this study was to compare the safety and efficacy of Resolute zotarolimus-eluting stents (ZES) (Medtronic Cardiovascular, Santa Rosa, California)…”
Get full text

Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia by van Gorselen, Edwin O. F, Diekman, Theo, Hessels, Jan, Verhorst, Patrick M. J, von Birgelen, Clemens

Get full text

Impact of analyzing less image frames per segment for radiofrequency-based volumetric intravascular ultrasound measurements in mild-to-moderate coronary atherosclerosis by Huisman, Jennifer, Hartmann, Marc, Mattern, Eline S. K., Mintz, Gary S., Basalus, Mounir W. Z., van Houwelingen, Gert K., Verhorst, Patrick M. J., von Birgelen, Clemens

“…Volumetric radiofrequency-based intravascular ultrasound (RF–IVUS) data of coronary segments are increasingly used as endpoints in serial trials of novel…”
Get full text

Microvolt T-wave alternans during exercise and pacing are not comparable by Kraaier, Karin, Verhorst, Patrick M.J., van der Palen, Job, van Dessel, Pascal F.H.M., Wilde, Arthur A.M., Scholten, Marcoen F.

“…Aims The absence of microvolt T-wave alternans (MTWA) identifies a group of patients who are at low risk for ventricular arrhythmia or sudden cardiac death…”
Get full text

Myocardial rupture: asymptomatic cover-up by Oortman, Remko M, Wagenaar, Lodewijk J, Verhorst, Patrick M

Get full text

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial by Sen, Hanim, Lam, Ming Kai, Tandjung, Kenneth, Basalus, Mounir W Z, de Man, Frits H A F, Louwerenburg, J Hans W, Stoel, Martin G, van Houwelingen, Gert K, Löwik, Marije M, Linssen, Gerard C M, Saïd, Salah A M, Nienhuis, Mark B, Verhorst, Patrick M J, van der Palen, Job, von Birgelen, Clemens

“…Drug-eluting stents (DES) were first used on-label - in simple patients with low clinical risk and easily accessible lesions. Currently, DES are increasingly…”
Get full text

Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up by Hartmann, Marc, von Birgelen, Clemens, Mintz, Gary S, Verhorst, Patrick M J, Erbel, Raimund

“…Glagov's histopathological observation and non-serial intravascular ultrasound studies (IVUS) concluded that compensatory coronary remodelling diminishes as…”
Get full text

A Shock Lead Intentionally Placed in the Left Ventricle by KRAAIER, KARIN, VERHORST, PATRICK M.J., SCHOLTEN, MARCOEN F.

“…The implantable cardioverter defibrillator is effective in reducing sudden cardiac death in high‐risk patients. The implantation procedure is usually simple;…”
Get full text

Relation Between Plaque Progression and Low-Density Lipoprotein Cholesterol During Aging as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound of the Left Main Coronary Artery by Hartmann, Marc, von Birgelen, Clemens, Mintz, Gary S., van Houwelingen, Gert K., Eggebrecht, Holger, Böse, Dirk, Wieneke, Heinrich, Verhorst, Patrick M.J., Erbel, Raimund

“…Because of the clinical benefit of lipid lowering in older patients, we hypothesized that the relation between low-density lipoprotein (LDL) cholesterol serum…”
Get full text

Remodeling Index Compared to Actual Vascular Remodeling in Atherosclerotic Left Main Coronary Arteries as Assessed With Long-Term (≥12 Months) Serial Intravascular Ultrasound by von Birgelen, Clemens, Hartmann, Marc, Mintz, Gary S., Böse, Dirk, Eggebrecht, Holger, Neumann, Till, Gössl, Mario, Wieneke, Heinrich, Schmermund, Axel, Stoel, Martin G., Verhorst, Patrick M.J., Erbel, Raimund

“…Remodeling Index Compared to Actual Vascular Remodeling in Atherosclerotic Left Main Coronary Arteries as Assessed With Long-Term (≥12 Months) Serial…”
Get full text

Major dehiscence of infected aortic valve prosthesis with "rocking motion" but without diastolic paravalvular regurgitation by Metz, Ethel, Hartmann, Marc, von Birgelen, Clemens, Haalebos, Max M P, Verhorst, Patrick M J

“…We present a case of a 66-year-old patient with infective endocarditis of an aortic valve bioprosthesis with major dehiscence and extensive "rocking motion"…”
Get full text

Dedicated calibration formulas permit correction of differences between measurements by different IVUS devices as demonstrated in atherosclerotic human coronary arteries in vitro by Hartmann, Marc, von Birgelen, Clemens, Mintz, Gary S, Deppermann, Nadine, Dirsch, Olaf, Stoel, Martin G, van Houwelingen, Gert K, Louwerenburg, Hans W, Verhorst, Patrick M J, Erbel, Raimund

“…Serial intravascular ultrasound (IVUS) measurements of coronary vessel dimensions are major endpoints of studies focusing on pharmacological interventions,…”
Get full text

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents by Tandjung, Kenneth, MD, Sen, Hanim, MD, Lam, Ming Kai, MD, Basalus, Mounir W.Z., MD, Louwerenburg, J. (Hans) W., MD, Stoel, Martin G., MD, van Houwelingen, K. Gert, MD, de Man, Frits H.A.F., MD, PhD, Linssen, Gerard C.M., MD, PhD, Saïd, Salah A.M., MD, PhD, Nienhuis, Mark B., MD, PhD, Löwik, Marije M., PhD, Verhorst, Patrick M.J., MD, PhD, van der Palen, Job, PhD, von Birgelen, Clemens, MD, PhD

“…Objectives The aim of this study was to assess the safety and efficacy of the implantation of Resolute zotarolimus-eluting stents (ZES) (Medtronic Inc., Santa…”
Get full text

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients by von Birgelen, Clemens, MD, PhD, Basalus, Mounir W.Z., MD, Tandjung, Kenneth, MD, van Houwelingen, K. Gert, MD, Stoel, Martin G., MD, Louwerenburg, J.(Hans) W., MD, Linssen, Gerard C.M., MD, PhD, Saïd, Salah A.M., MD, PhD, Kleijne, Miep A.W.J., MD, Sen, Hanim, MD, Löwik, Marije M., PhD, van der Palen, Job, PhD, Verhorst, Patrick M.J., MD, PhD, de Man, Frits H.A.F., MD, PhD

“…Objectives The aim of this study was to compare the safety and efficacy of Resolute zotarolimus-eluting stents (ZES) (Medtronic Cardiovascular, Santa Rosa,…”
Get full text